Spinal cord injury pharmacotherapy: Current research & development and competitive commercial landscape as of 2015.

Jason R GuercioJason E KralicEric J MarrotteMichael L James

Published in: The journal of spinal cord medicine (2018)

There is urgent need to develop disease-modifying therapy for SCI, yet the commercial landscape remains small and highly fragmented with a paucity of novel late-stage compounds in R&D.

Keyphrases

spinal cord injury
single cell
spinal cord
neuropathic pain
smoking cessation